Skip to main content
  • Poster presentation
  • Open access
  • Published:

Characterization of carbapenem-resistant Acinetobacter baumannii strains isolated from hospitalized patients in Palestine

Introduction

The increase in the incidence of hospital acquired infections due to A. baumannii (MDR-AB) mandates characterizing the strains circulating in Palestinian hospitals.

Objectives

Determine the antibiogram of the MDR-AB. Identify the genes responsible for the carbapenem and the aminoglycosides resistance. Identify the presence of the two virulence genes OmpA and epsA. Determine the strains types of the MDR-AB isolated from Palestinian hospitals.

Methods

72 single patients MDR-AB collected from all over Palestine, except Gaza, were included in the study. The CLSI guidelines were followed to determine the antibiogram of the isolates. The presence of the carbapenem resistance genes blaOXA-58, blaOXA-23, blaOXA-24, blaKPC, blaNDM and the aminoglycoside resistance genes aphA6 and aphA1 were determined by PCR. Moreover, the two A. baumannii virulence genes OmpA and epsA, were evaluated by PCR. Finally MLST was performed on 13 isolates to determine the Strain Type (ST) of the isolates.

Results

All the isolates were resistant to all the β–lactam antibiotics including the carbapenems. Of the 72 isolates, 77.9% positive for blaOXA-23, 14.7% positive for blaOXA-24, 4.4% positive for blaOXA-58. In addition, 5.88% and 0% were positive for blaNDM and blaKPC, respectively. Moreover, of the 72 isolates none were positive for aphA6 gene while 92% were positive to the aphA1 gene. The only two antibiotics that showed a non-resistant profile were colistin sulfate (78%) and tigecycline (95%). 98.5% of the isolates possessed the OmpA biofilm producing virulence gene. Finally, MLST of 13 isolates revealed that more than one strain of A. baumannii is circulating in the Palestinian hospitals, 7 isolates ST 208 (53.8%), 2 isolates ST 218 (15.4%), 1 isolates ST231 (7.7%), 1 isolates ST348 (7.7%) and 2 isolates new ST (15.4%).

Conclusion

The detection of these extremely drug resistant pathogens in Palestine was a strong reminder of the importance of mandating that the infection control programs in all the hospitals must be active in order to reduce the spread of these deadly pathogens.

Disclosure of interest

None declared.

Author information

Authors and Affiliations

Authors

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Handal, R., Qunibi, L., Sahouri, I. et al. Characterization of carbapenem-resistant Acinetobacter baumannii strains isolated from hospitalized patients in Palestine. Antimicrob Resist Infect Control 4 (Suppl 1), P136 (2015). https://doi.org/10.1186/2047-2994-4-S1-P136

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/2047-2994-4-S1-P136

Keywords